4.7 Article

Cell cycle arrest and apoptosis induced by O-acetyl-GD2-specific monoclonal antibody 8B6 inhibits tumor growth in vitro and in vivo

期刊

CANCER LETTERS
卷 333, 期 2, 页码 194-204

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2013.01.032

关键词

Ganglioside; O-Acetyl-GD2; Cell cycle arrest; Apoptosis; Therapeutic antibody; Immunotherapy

类别

资金

  1. Agence Nationale pour la Recherche
  2. Ligue Nationale Contre le Cancer
  3. Institut National du Cancer and Canceropole Grand Guest (MAB IMPACT
  4. IMProving ACTivation of FcgRIIIa-expressing effector cells, pharmacogenetic-based optimistation of monoclonal antibody therapy for cancer, federative project)
  5. Fondation des Projets de l'Universite de Nantes
  6. AAIR LI-CHENS
  7. Fondation de la Recherche Medicale
  8. Societe Francaise de lutte contre les Cancers at les leucemies l'Enfant et de l'adolescent, l'Etoile de Martin, and les Bagouz' a Manon
  9. MAB IMPACT

向作者/读者索取更多资源

O-Acetyl-GD2 ganglioside is suitable antigen for tumor immunotherapy with specific therapeutic antibody. Here, we investigate the anti-tumor activity of O-acetyl-GD2-specific monoclonal antibody 8B6 on O-acetyl-GD2-positive tumor cells. The results indicated that mAb 8B6 induced growth inhibition of O-acetyl-GD2-expressing tumor cell lines in vitro with features of cell cycle arrest and apoptosis. Monoclonal antibody 8B6 treatment was also very effective in suppression of tumor growth in mice by reducing the proliferation index and increasing the apoptotic index. Such a study represents a useful framework to optimize immunotherapy with O-acetyl-GD2-specific antibody in combination with chemotherapeutic agents. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据